ArticleFood technology and biotechnology
Date Fruits and Their Products for Almond Beverage Fortification: Assessment of Beverages and Resulting Residues.
Article in Food technology and biotechnology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Research background: The shift towards plant-based beverages, particularly almond drinks, has increased the need to develop innovative products using fruits and herbal extracts to improve their nutritional and sensory properties. In this study, date palm fruits, Deglet Nour variety (tamr stage) and Besser Helou variety (khalal stage), and two Deglet Nour-derived products (date powder and syrup) were evaluated as fortifying ingredients in almond drinks. The antioxidant and nutritional properties of the recovered solid residues were also evaluated. Experimental approach: The beverage-making process involved grinding blanched almonds into flour ( Results and conclusions: The addition of date-based ingredients to almonds significantly reduced the extraction yields of beverages, with the reduction being least significant in syrup, moderate in Deglet Nour and Besser Helou varieties, and most significant in date powder. Combining almonds with any form of dates significantly increased carbohydrate and ash mass fraction, energy value and antioxidant activity of beverages, as confirmed by both FRAP and DPPH assays. Phenolics previously present in almonds and dates were found to multiply, while new ones appeared in both drinks and residues, such as caffeic acid. A distinctive rheological profile was observed in beverages fortified with Deglet Nour, date syrup and date powder, characterised by shear thickening at low shear rates and a transition to shear thinning at higher shear rates. Sensory evaluations of enriched drinks revealed that dates provided new colour shades, increased sweetness and mouthfeel viscosity, and improved almond taste perception. Date powder-based drinks received the highest overall acceptability rating, while syrup-based drinks received the lowest. Combining date ingredients with almonds reduced the fat and protein mass fraction of residues while increasing carbohydrate mass fraction. Quinic acid and quercetin were the prevalent phenolic acids and flavonoids in almond residue, while caffeic acid and luteolin were the primary compounds in date-based residues. Novelty and scientific contribution: This study presents the first comprehensive evaluation of the nutritional, rheological, antioxidant and sensory properties of almond beverages fortified with date-based ingredients. The nutritional and antioxidant properties of the raw ingredients and the produced residues were also assessed. The results suggest that additional phenolics may be generated in fortified almond drinks during processing and show that the resulting date residue is as relevant as potent dietary supplements.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.